PROF Q3 2024 Earnings — Profound Medical Corp. Revenue & Financial Results | Market Cap Arena

PROFProfound Medical Corp.

$167M

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$4M+121.6% YoY

Gross Profit

$2M63.8% margin

Operating Income

$12M317.4% margin

Net Income

-$13M-330.6% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

+71.5%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$604,000

Balance Sheet

Total Assets

$42M

Total Liabilities

$11M

Stockholders' Equity

$31M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+121.6%
Gross Profit	$2M	$1M	+130.4%
Operating Income	$12M	-$7M	+285.3%
Net Income	-$13M	-$6M	-127.6%